Insiders · Profile

KIRSKE DAVID

Chief Financial Officer at X4 Pharmaceuticals. Filing since 12 May 2026. CIK 0001276750

Company

Date

Role

Action

Amount

Of holding

1 Oct 2026

Chief Financial Officer

Sold at will

11,767

$33.66K

7.0%

30 Jun 2026

Chief Financial Officer

Sold at will

8,543

$36.43K

4.8%

12 May 2026

Chief Financial Officer

Sold at will

16,961

$72.82K

8.8%

3 decisions on file.